The complexity and heterogeneity of chronic immune diseases has led to barriers in the development of novel therapies and treatments for patients. However, by looking to the global ecosystem, harnessing scientific advances in understanding disease pathophysiology and identifying and employing biomarkers for mechanistic stratification, there is hope.
Join Johnson & Johnson Innovation on September 29 as they welcome experts in the space to discuss precision medicine approaches in immune-mediated diseases and the opportunities they see to hopefully make precision medicine a reality for patients: https://jji.jnj/PrecisionMed